Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

休市中 05-26 16:00:00 EDT

126.24

-0.23

-0.18%

盘后126.05

-0.19-0.15%

19:59 EDT

最高128.49	最低124.25	成交量364.44万
今开128.49	昨收126.47	日振幅3.35%
总市值481.24亿	流通市值434.31亿	总股本3.81亿
成交额4.58亿	换手率1.06%	流通股本3.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":126.24,"timestamp":1685131200000,"preClose":126.47,"halted":0,"volume":3644408,"hourTrading":{"tag":"盘后","latestPrice":126.05,"preClose":126.24,"latestTime":"19:59 EDT","volume":240574,"amount":30369543.2152,"timestamp":1685145589301},"delay":0,"floatShares":344032700,"shares":381209341,"eps":11.665952,"marketStatus":"休市中","marketStatusCode":7,"change":-0.23,"latestTime":"05-26 16:00:00 EDT","open":128.49,"high":128.49,"low":124.2501,"amount":457973729.55024,"amplitude":0.033525,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":11.665952,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1685433600000},"adr":0,"listingDate":1544158800000,"adjPreClose":126.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":128.35,"preClose":126.47,"latestTime":"09:29 EDT","volume":13286,"amount":1703631.09644,"timestamp":1685107799999},"postHourTrading":{"tag":"盘后","latestPrice":126.05,"preClose":126.24,"latestTime":"19:59 EDT","volume":240574,"amount":30369543.2152,"timestamp":1685145589301},"volumeRatio":0.8445564963322177,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":false,"expireDate":1689912000000,"strike":"190.0","timestamp":1685129678618,"price":64.05000305175781,"volume":1050,"amount":6725250,"type":"-"}]}},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"2338121291","title":"重磅｜美国疫苗厂商Moderna1亿美金在上海注册公司，加大中国投资布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2338121291","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2338121291?lang=zh_CN&edition=full","pubTime":"2023-05-26 14:39","pubTimestamp":1685083140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052614400680667d13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052614400680667d13&s=b","is_publish_highlight":false},{"id":"2337890630","title":"美股异动 | 抗疫概念股走低 诺瓦瓦克斯医药(NVAX.US)跌超5.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2337890630","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2337890630?lang=zh_CN&edition=full","pubTime":"2023-05-24 23:18","pubTimestamp":1684941503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052423253283d5e375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052423253283d5e375&s=b","is_publish_highlight":false},{"id":"2337695102","title":"Moderna披露mRNA疗法用于罕见病I/II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2337695102","media":"医药魔方","top":-1,"share":"https://www.laohu8.com/m/news/2337695102?lang=zh_CN&edition=full","pubTime":"2023-05-22 07:41","pubTimestamp":1684712486,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230522074456823b0473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230522074456823b0473&s=b","is_publish_highlight":false},{"id":"2334279172","title":"摩根士丹利：将Moderna(MRNA.O)目标价从185美元下调至153美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334279172","media":"老虎证券","top":-1,"share":"https://www.laohu8.com/m/news/2334279172?lang=zh_CN&edition=full","pubTime":"2023-05-10 03:43","pubTimestamp":1683661390,"startTime":"0","endTime":"0","summary":"【摩根士丹利：将Moderna(MRNA.O)目标价从185美元下调至153美元】美港电讯APP 5月10日讯，摩根士丹利将Moderna的目标价从185美元下调至153美元，并保持对该股的持股观望评级，此前该公司公布了第一季度的业绩，并重申了2023年的指引。报告发布后，大摩针对该公司第一季度的业绩、趋势和最近的数据对其模型进行了一些调整，同时还将其现金流折现分析的折现期向前推移。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051003471684444c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051003471684444c7e&s=b","is_publish_highlight":false},{"id":"2333040041","title":"滴血验癌欺诈69亿元被判11年“女骗子”，在做最后的挣扎","url":"https://stock-news.laohu8.com/highlight/detail?id=2333040041","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2333040041?lang=zh_CN&edition=full","pubTime":"2023-05-08 16:37","pubTimestamp":1683535020,"startTime":"0","endTime":"0","summary":"霍尔姆斯罕见地接受了外媒的长篇采访","market":"hk","thumbnail":"https://img.huxiucdn.com/article/cover/202305/08/160833980351.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202305/08/160833980351.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.huxiu.com/article/1474576.html","is_publish_highlight":false},{"id":"2333489680","title":"美银证券：下调Moderna(MRNA.O)目标价至175美元 评级中性","url":"https://stock-news.laohu8.com/highlight/detail?id=2333489680","media":"老虎证券","top":-1,"share":"https://www.laohu8.com/m/news/2333489680?lang=zh_CN&edition=full","pubTime":"2023-05-05 23:50","pubTimestamp":1683301815,"startTime":"0","endTime":"0","summary":"【美银证券：下调Moderna(MRNA.O)目标价至175美元 评级中性】美港电讯APP 5月5日讯，美银证券发表研报指，Moderna今年首季表现稳健，新冠疫苗收入增长的推动下，收入及盈利均有所上升，虽然业绩向好，仍有投资者对公司次季新冠相关业务收入指引及全年目标感到失望。美银表示，目前仍然对新冠相关业务发展持审慎看法，有待管理层进行更进一步解说。展望未来产品管线，该行对莫德纳的下一步增长未有没有明确的看法，考虑到季节性流感疫苗mRNA-1010的延迟，以及对其疗效的担忧，美银相应下调季节性流感相关收入预测，目标价降至175美元，重申中性评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050600004281fe66da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050600004281fe66da&s=b","is_publish_highlight":false},{"id":"2333178465","title":"【券商聚焦】美银：对莫德纳(MRNA)新冠业务持审慎看法 下调目标价至175美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2333178465","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2333178465?lang=zh_CN&edition=full","pubTime":"2023-05-05 15:59","pubTimestamp":1683273580,"startTime":"0","endTime":"0","summary":"美银证券发研报指，莫德纳(MRNA)今年首季表现稳健，新冠疫苗收入增长的推动下，收入及盈利均有所上升，虽然业绩向好，仍有投资者对公司次季新冠相关业务收入指引及全年目标感到失望。美银表示，目前仍然对新冠相关业务发展持审慎看法，有待管理层进行更进一步解说。展望未来产品管线，该行对莫德纳的下一步增长未有没有明确的看法，考虑到季节性流感疫苗mRNA-1010的延迟，以及对其疗效的担忧，美银相应下调季节性流感相关收入预测，目标价降至175美元，重申“中性”评级。该股现报134.33美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=5f7c15d64c3f3b5b2a79fc1d275b4aa3","is_publish_highlight":false},{"id":"2332195409","title":"美股异动 | 一季度财报超预期 Moderna(MRNA.US)涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2332195409","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2332195409?lang=zh_CN&edition=full","pubTime":"2023-05-04 23:08","pubTimestamp":1683212934,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，Moderna(MRNA.US)在公布一季度财报后股价走高，截至发稿，该股涨超5%，报137.47美元。公司Q1录得营收18.6亿美元和净利润0.79亿美元，远超市场预期。新冠疫苗业务营收18.3亿美元，远超预期的11.4亿美元。Moderna表示，计划在2024年将其用于老年人的实验性呼吸道合胞病毒(RSV)疫苗进行商业化。该公司还准备推出六种主要的呼吸系统疫苗(新冠、RSV，流感和联合疫苗)，预计到2027年的年度销售额将达到80亿至150亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/926165.html","is_publish_highlight":false},{"id":"2332416653","title":"Moderna(MRNA)：仍预计本财年销售成本约为产品销售额的35-40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2332416653","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2332416653?lang=zh_CN&edition=full","pubTime":"2023-05-04 19:51","pubTimestamp":1683201118,"startTime":"0","endTime":"0","summary":"周四美股盘前，Moderna(MRNA)公布2023年第一季度财务业绩。数据显示，该公司Q1营收18.6亿美元，预期11.8亿美元；净利润8000万美元，预期净亏损6.5亿美元。第一季度研发支出为11.3亿美元，市场预期为10.6亿美元。截至第一季度末，现金及现金等价物为34.4亿美元，市场预期为26.9亿美元。展望未来，仍预计上半年产品总销售额约20亿美元，第二季度产品销售额为2亿-3亿美元。仍预计本财年销售成本约为产品销售额的35-40%。仍预计全年支出约为60亿美元，其中研发支出约为45亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050419520581fad48f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050419520581fad48f&s=b","is_publish_highlight":false},{"id":"2332165814","title":"Moderna(MRNA.US)Q1营收同比下降近70% 每股收益0.19美元好于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2332165814","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2332165814?lang=zh_CN&edition=full","pubTime":"2023-05-04 19:25","pubTimestamp":1683199533,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月4日美股盘前，Moderna公布了2023年第一季度财务业绩。财报显示，Moderna Q1总营收为18.62亿美元，但远好于市场预期的11.8亿美元，较上年同期的60.66亿美元下降近70%，主要是因为新冠疫苗的销售下降。净利润为7900万美元，上年同期为36.57亿美元;摊薄后每股收益为0.19美元，好于市场预期的每股亏损1.75美元，上年同期为每股收益8.58美元。Moderna表示，计划在2024年将其用于老年人的实验性呼吸道合胞病毒疫苗进行商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/926022.html","is_publish_highlight":false},{"id":"1190561027","title":"Moderna第一季度营收18.6亿美元，远超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1190561027","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1190561027?lang=zh_CN&edition=full","pubTime":"2023-05-04 18:34","pubTimestamp":1683196474,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true},{"id":"2331069325","title":"下周(5.1-5.7)全球市场大事提醒","url":"https://stock-news.laohu8.com/highlight/detail?id=2331069325","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2331069325?lang=zh_CN&edition=full","pubTime":"2023-04-30 16:43","pubTimestamp":1682844190,"startTime":"0","endTime":"0","summary":"美联储利率决议重磅来袭；巴菲特股东大会即将召开；苹果、汇丰将发布最新财报；劳动节来临，关注港A休市安排……","market":"hk","thumbnail":"https://img3.gelonghui.com/54ed0-41ca8dd9-92bd-4dd5-90d5-689e35bcb2c5.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/54ed0-41ca8dd9-92bd-4dd5-90d5-689e35bcb2c5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/599762","is_publish_highlight":false},{"id":"2330267263","title":"硅谷“血检女骗”提出上诉 暂时不去监狱报到","url":"https://stock-news.laohu8.com/highlight/detail?id=2330267263","media":"新浪科技","top":-1,"share":"https://www.laohu8.com/m/news/2330267263?lang=zh_CN&edition=full","pubTime":"2023-04-27 09:58","pubTimestamp":1682560680,"startTime":"0","endTime":"0","summary":"新浪科技讯 北京时间4月27日上午消息，据报道，美国血液检测公司Theranos的创始人伊丽莎白·霍尔姆斯 因欺诈被判处11年牢狱，法官判决她从本周四开始服刑，但是据最新报道，霍尔姆斯在最后一刻提出上诉，她本周不会去监狱报到。　　当地时间周二，霍尔姆斯的律师团向位于加州旧金山的美国第九巡回上诉法庭提起上诉，根据法庭流程，这意味着霍尔姆斯可以暂时依靠保释维持人身自由。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2023-04-27/doc-imyruraw1882789.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2023-04-27/doc-imyruraw1882789.shtml","is_publish_highlight":false},{"id":"2330310425","title":"古根海姆：首次覆盖Moderna(MRNA.O) 予中性评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2330310425","media":"老虎证券","top":-1,"share":"https://www.laohu8.com/m/news/2330310425?lang=zh_CN&edition=full","pubTime":"2023-04-27 03:37","pubTimestamp":1682537872,"startTime":"0","endTime":"0","summary":"【古根海姆：首次覆盖Moderna(MRNA.O) 予中性评级】美港电讯APP 4月27日讯，古根海姆分析师Evan Wang首次覆盖Moderna，予其中性评级，但未给出目标价。该分析师表示，新冠疫情仍然是一个重要的近期驱动力，尽管“Moderna不仅仅是一个关于新冠的故事”，它已经扩展到了呼吸道合胞病毒(RSV)、流感、肿瘤学、治疗学和基因编辑领域，他认为2023年的指引“可能反映在股价上”。2023年的关键是实现更新的流感疫苗mRNA-1010的预期，虽然最好的猜测是疫苗成功，但分析师比华尔街预期更谨慎，并警告称“失败可能会导致实质性的下行修正”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304270351518283ee08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304270351518283ee08&s=b","is_publish_highlight":false},{"id":"2328974382","title":"Moderna与IBM合作将人工智能、量子计算于应用于mRNA疫苗研发中","url":"https://stock-news.laohu8.com/highlight/detail?id=2328974382","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2328974382?lang=zh_CN&edition=full","pubTime":"2023-04-20 23:08","pubTimestamp":1682003299,"startTime":"0","endTime":"0","summary":"格隆汇4月20日丨Moderna和IBM两家公司周四宣布，正在合作使用人工智能和量子计算来推进mRNA技术，这是该公司重磅Covid疫苗的核心开发。两家公司表示，他们签署了一项协议，允许 Moderna 访问 IBM 的量子计算系统。根据协议，Moderna的科学家还可以使用IBM的人工智能模型MoLFormer，可根据训练过的数据创建新内容的算法。两家公司表示，Moderna将使用IBM的模型来了解“潜在mRNA药物的特征”，并设计一类新的疫苗和疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304202308448427c623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304202308448427c623&s=b","is_publish_highlight":false},{"id":"2328478308","title":"Moderna和默克公布治疗黑色素瘤的癌症疫苗详细IIb期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2328478308","media":"中金在线","top":-1,"share":"https://www.laohu8.com/m/news/2328478308?lang=zh_CN&edition=full","pubTime":"2023-04-17 16:14","pubTimestamp":1681719267,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨默克(MRK.US)和Moderna(MRNA.US)在周日的一次医疗活动中公布了其癌症疫苗mRNA-4157(V940)联合KEYTRUDA治疗黑色素瘤的IIb期结果。此次IIb期实验是探究mRNA-4157/V940与keytruda联用作为完全切除的III/IV期黑色素瘤患者的辅助治疗。两家公司表示，与单独使用Keytruda相比，这种新型治疗方案将复发或死亡的风险降低了44%。皮肤癌、黑色素瘤患者的无复发生存期(RFS)得到了统计学上的显著改善，并具有临床意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230417162124827b4db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230417162124827b4db2&s=b","is_publish_highlight":false},{"id":"2328407664","title":"莫德纳(MRNA)和默沙东(MRK)的癌症疫苗显示出进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2328407664","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2328407664?lang=zh_CN&edition=full","pubTime":"2023-04-17 10:45","pubTimestamp":1681699529,"startTime":"0","endTime":"0","summary":"莫德纳和默沙东近日在美国癌症研究协会年会上表示，皮肤癌中晚期患者，在接受莫德纳基于mRNA的癌症疫苗与默沙东的重点免疫药物Keytruda的组合疗法后，约有79%在18个月后未复发，而仅接受默沙东的Keytruda治疗的的患者有62%未复发。据悉，Keytruda是目前非常常用的黑色素瘤辅助疗法，可以降低癌症复发风险。而mRNA疫苗可根据每个患者的癌细胞特征提供个性化治疗，对以往未获得有效治疗的患者有望提供新的治疗机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=d8c0f8017ff9b2abc1f3581b649c8860","is_publish_highlight":false},{"id":"2328429445","title":"Moderna(MRNA.US)和默沙东(MRK.US)联合疗法对皮肤癌患者有积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2328429445","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2328429445?lang=zh_CN&edition=full","pubTime":"2023-04-17 08:51","pubTimestamp":1681692671,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Moderna和默沙东周日表示，一项关键的研究显示，与单独的免疫疗法相比，在重磅药物 Keytruda 中添加个性化癌症疫苗使更多的黑色素瘤患者得到缓解。随着新冠疫苗需求降温，癌症疫苗是Moderna疫情后战略的重要组成部分。Moderna分析了每位患者肿瘤的基因序列，从而制造出一种疫苗，使免疫系统能够识别异常生长的标记物。默沙东和 Moderna 计划在已经使用 Keytruda 治疗的其他癌症中测试该联合疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/911473.html","is_publish_highlight":false},{"id":"2326912262","title":"美银：Moderna(MRNA.US)股价或继续承压 予“中性”评级及目标价200美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2326912262","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2326912262?lang=zh_CN&edition=full","pubTime":"2023-04-12 19:42","pubTimestamp":1681299732,"startTime":"0","endTime":"0","summary":"美银予Moderna“中性”评级，目标价为200美元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20230412/20230412194232_62084.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230412/20230412194232_62084.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/909626.html","is_publish_highlight":false},{"id":"1166375973","title":"盘前 | 市场交投情绪谨慎！美股指期货弱势震荡","url":"https://stock-news.laohu8.com/highlight/detail?id=1166375973","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1166375973?lang=zh_CN&edition=full","pubTime":"2023-04-11 20:15","pubTimestamp":1681215320,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0343},{"period":"3month","weight":-0.0935},{"period":"6month","weight":-0.2844},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.2972}],"websiteUrl":"http://www.modernatx.com","compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.0387},{"period":"3month","weight":0.0596},{"period":"6month","weight":0.044},{"period":"1year","weight":0.0363},{"period":"ytd","weight":0.0983}],"name":"Moderna, Inc.","description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。他们正在创建一种新的基于信使RNA或mRNA的转化药物，以改善患者的生活。从一开始，他们设计了他们的策略和操作，以在很长的时间范围内实现mRNA在各种人类疾病中的全部潜在价值和影响。该公司建立并持续投资一个以推进mRNA药物的技术前沿为目的的平台，以推进mRNA药物的研发。他们制定并继续对可扩展的基础设施和能力进行前瞻性投资，以寻求能够反映mRNA机会广度的潜在药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.088013},{"month":2,"riseRate":0.4,"avgChangeRate":0.043053},{"month":3,"riseRate":0.6,"avgChangeRate":0.025848},{"month":4,"riseRate":0.6,"avgChangeRate":0.165158},{"month":5,"riseRate":0.6,"avgChangeRate":0.040275},{"month":6,"riseRate":0.5,"avgChangeRate":0.000405},{"month":7,"riseRate":0.75,"avgChangeRate":0.175583},{"month":8,"riseRate":0.5,"avgChangeRate":-0.013036},{"month":9,"riseRate":0.75,"avgChangeRate":0.00452},{"month":10,"riseRate":0.5,"avgChangeRate":0.04351},{"month":11,"riseRate":1,"avgChangeRate":0.417604},{"month":12,"riseRate":0.25,"avgChangeRate":-0.153394}],"exchange":"NASDAQ","nameEN":"Moderna, Inc.","compareStock":{"symbol":"SPY","name":"标普500ETF"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}